It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
OPCH’s FA Score shows that 0 FA rating(s) are green whileRHE’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
OPCH’s TA Score shows that 4 TA indicator(s) are bullish.
OPCH (@Medical/Nursing Services) experienced а -2.45% price change this week, while RHE (@Medical/Nursing Services) price change was -21.50% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.01%. For the same industry, the average monthly price growth was -3.13%, and the average quarterly price growth was +1650.83%.
OPCH is expected to report earnings on Feb 20, 2025.
RHE is expected to report earnings on Nov 18, 2024.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
OPCH | RHE | OPCH / RHE | |
Capitalization | 5.82B | 4.71M | 123,598% |
EBITDA | 472M | -831K | -56,799% |
Gain YTD | -34.906 | -22.611 | 154% |
P/E Ratio | 22.16 | 0.13 | 16,528% |
Revenue | 4.3B | 22.8M | 18,868% |
Total Cash | 344M | 1.43M | 24,107% |
Total Debt | 1.17B | 54.3M | 2,147% |
OPCH | RHE | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 64 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 38 Fair valued | |
PROFIT vs RISK RATING 1..100 | 50 | 99 | |
SMR RATING 1..100 | 57 | 100 | |
PRICE GROWTH RATING 1..100 | 89 | 85 | |
P/E GROWTH RATING 1..100 | 76 | 94 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RHE's Valuation (38) in the Real Estate Investment Trusts industry is somewhat better than the same rating for OPCH (78) in the null industry. This means that RHE’s stock grew somewhat faster than OPCH’s over the last 12 months.
OPCH's Profit vs Risk Rating (50) in the null industry is somewhat better than the same rating for RHE (99) in the Real Estate Investment Trusts industry. This means that OPCH’s stock grew somewhat faster than RHE’s over the last 12 months.
OPCH's SMR Rating (57) in the null industry is somewhat better than the same rating for RHE (100) in the Real Estate Investment Trusts industry. This means that OPCH’s stock grew somewhat faster than RHE’s over the last 12 months.
RHE's Price Growth Rating (85) in the Real Estate Investment Trusts industry is in the same range as OPCH (89) in the null industry. This means that RHE’s stock grew similarly to OPCH’s over the last 12 months.
OPCH's P/E Growth Rating (76) in the null industry is in the same range as RHE (94) in the Real Estate Investment Trusts industry. This means that OPCH’s stock grew similarly to RHE’s over the last 12 months.
OPCH | |
---|---|
RSI ODDS (%) | 3 days ago74% |
Stochastic ODDS (%) | 3 days ago78% |
Momentum ODDS (%) | 3 days ago69% |
MACD ODDS (%) | 3 days ago63% |
TrendWeek ODDS (%) | 3 days ago66% |
TrendMonth ODDS (%) | 3 days ago66% |
Advances ODDS (%) | 20 days ago71% |
Declines ODDS (%) | 5 days ago64% |
BollingerBands ODDS (%) | 3 days ago73% |
Aroon ODDS (%) | 3 days ago72% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ULE | 10.78 | 0.04 | +0.42% |
ProShares Ultra Euro | |||
GVI | 104.48 | 0.14 | +0.13% |
iShares Intermediate Govt/Crdt Bd ETF | |||
BEMB | 52.37 | -0.03 | -0.06% |
iShares J.P. Morgan Brd USD Emr MktBdETF | |||
XBJL | 33.90 | -0.16 | -0.48% |
Innovator US Eq Acclrtd 9 Bffr ETF Jul | |||
JHSC | 41.49 | -0.45 | -1.07% |
JHancock Multifactor Small Cap ETF |
A.I.dvisor indicates that over the last year, OPCH has been loosely correlated with CHE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if OPCH jumps, then CHE could also see price increases.
Ticker / NAME | Correlation To OPCH | 1D Price Change % | ||
---|---|---|---|---|
OPCH | 100% | -1.17% | ||
CHE - OPCH | 58% Loosely correlated | -0.77% | ||
DVA - OPCH | 44% Loosely correlated | +3.87% | ||
ADUS - OPCH | 41% Loosely correlated | -1.88% | ||
USPH - OPCH | 33% Loosely correlated | +0.29% | ||
PNTG - OPCH | 33% Poorly correlated | -1.47% | ||
More |
A.I.dvisor tells us that RHE and OPCH have been poorly correlated (+18% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RHE and OPCH's prices will move in lockstep.
Ticker / NAME | Correlation To RHE | 1D Price Change % | ||
---|---|---|---|---|
RHE | 100% | +12.14% | ||
OPCH - RHE | 18% Poorly correlated | -1.17% | ||
BACK - RHE | 10% Poorly correlated | -4.67% | ||
DVA - RHE | 10% Poorly correlated | +3.87% | ||
PNTG - RHE | 10% Poorly correlated | -1.47% | ||
BKDT - RHE | 9% Poorly correlated | N/A | ||
More |